TCS, HDFCBANK, SBI Liquid Fund (G)
Vikas Lifecare Ltd.
Vikas Lifecare
NSE
₹ 0.00
0.00 (0.00)%
Chemicals
Small-cap
With a market cap of ₹18.90L Cr.
Moderate Volatility
Stock is 1.13x as volatile as index
| EX-Date | Purpose |
|---|---|
| 17 05 2021 | Right Issue of Equity Shares |
| 25 06 2021 | Audited Results |
| 09 07 2021 | Quarterly Results |
| 19 07 2021 | Inter alia, to consider and approve review the status of company?s ongoing debt reduction program and other agendas. |
| 25 08 2021 | Rights Issue & Inter-alia,: i. to consider increase in Authorized Share Capital of the Company and consequent alteration in ?Capital Clause? of the Memorandum of Association of the Company to accommodate the further issuance of share; ii. to consider alteration of Article of Association of the Company to align the same with the existing business requirement of the Company and other applicable provisions; iii. to consider the proposal for acquisition of Advik Laboratories Limited through floating an Open Offer / an SPA (Special Purpose Agreement). iv. to consider the various proposals to select and appoint a professional technocommercial agency to guide the Ethanol project through the various statutory processes, registrations, approvals and for the ground work for establishment of the project. v. to consider the proposal for procurement of 2 land chunks measuring 15.6 Acres and 25 Acres respectively, valued at a total Rs 390 Million at Naurangpura, Kothputli, Rajasthan for the various activities of the Agri Business Division including Crop Storage & Preservation, Crop Research and Development and Cultivation. vi. to consider fund raising upto Rs. 50 Crores by way issuance of equity share of the company, partly paid up or fully paid-up, in one or more trenches, on Right Basis to the existing shareholders of the Company; vii. to fix the date, time, venue, mode of convening the 26th Annual General Meeting (?AGM?) of the company and approve notice calling the AGM along with Directors Report, secretarial Audit Report, corporate Governance Report with certificates and other matters/items incidental thereto; viii. to consider and approve the appointment of KMPs, Directors, if any; and ix. any other matter, with the permission of the Chair. |
| 14 10 2021 | Quarterly Results |
| 26 10 2021 | Rights Issue |
| 10 01 2022 | Quarterly Results |
| 15 02 2022 | General Purpose |
| 28 05 2022 | Audited Results |
| 25 07 2022 | Quarterly Results |
| 03 09 2022 | A.G.M. |
| 21 10 2022 | Quarterly Results |
| 25 01 2023 | Quarterly Results & Inter alia,to consider, review and evaluate the progress in various businesses, strategies and their recent developments, and to consider and evaluate certain new business opportunities which could advantageously be combined with the Company s existing line of business and competencies, and all other matters connected therewith and incidental thereto. |
| 19 05 2023 | Audited Results |
| 23 05 2023 | Increase in Authorised Capital (Revised) & Audited Results The Board Meeting to be held on 19/05/2023 has been revised to 23/05/2023 The Board Meeting to be held on 19/05/2023 has been revised to 23/05/2023 |
| 12 08 2023 | Quarterly Results |
| 31 08 2023 | Preferential Issue of shares |
| 06 09 2023 | Preferential Issue of shares |
| 17 10 2023 | Quarterly Results |
| 13 02 2024 | Quarterly Results |
| 22 10 2024 | Quarterly Results |
| 20 12 2024 | Inter-alia, to consider issuance of securities, in order to further augment the long-term resources of the Company, subject to all statutory approvals, and to appoint intermediaries for this purpose and to amend the Capital Clause of the Memorandum of the Company; |
| 14 02 2025 | Quarterly Results |
News
No News data available
